Loading organizations...
Loading organizations...
Key people at VIB.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 15, 2023 | dualyx | $43.5M Series A | Aneta Sottil, Juliette Audet, Ena Prosser | Benhamou Global Ventures, GFF, High-Tech Grunderfonds, PMV, V-Bio Ventures |
| Dec 21, 2021 | Aphea.Bio | $20.3M Series B | Hendrik Van | Agri Investment Fund, Gemma Frisius Fund, PMV, Qbic II, V-Bio Ventures, VIVES Louvain Technology Fund |
| Jul 9, 2021 | Muna Therapeutics | $73.0M Series A | Droia Ventures, LSP, Morten Graugaard Døssing, Sofinnova Partners | LS Polaris Innovation Fund, Sanofi Ventures, V-Bio Ventures |
| May 24, 2021 | ExeVir Bio | $50.0M Series A | Philippe Monteyne | Belgian family offices, Noshaq, Sambrinvest, Stef HEYLEN, MD, Caroline THIELEN, Erica Whittaker, Katja Rosenkranz, Jerome Van Biervliet, Joël Henneghien |
| Jul 28, 2020 | ExeVir Bio | $27.0M Other Equity | Philippe Monteyne | SFPI-FPIM, Erica Whittaker, Katja Rosenkranz, Jerome Van Biervliet |
| Mar 9, 2017 | Biotalys | $11.7M Series B Extension | — | Agri Investment Fund, Biovest, Gimv, Globachem Group, Madeli Participaties, PMV, Qbic, Sofinnova Partners |
| Feb 11, 2013 | Multiplicom | $7.4M Other Equity | — | Gimv, PMV, Qbic, RMM |
| Jan 11, 2013 | Biotalys | $6.7M Other Equity | Gimv | PMV, Qbic, SOFI |
| Dec 1, 2011 | argenx | $37.1M Series B | Michael B. Sheffery, Isabelle de Cremoux | BioGeneration Ventures, Credit Agricole Private Equity, Erasmus Biomedical Fund, Forbion, LSP, Thuja Capital |
| Apr 29, 2011 | Multiplicom | $3.0M Series A | Gimv | University of Antwerp |
